Share This Article:

Comparative prevalence of MRSA in two Nepalese tertiary care hospitals

Abstract Full-Text HTML Download Download as PDF (Size:363KB) PP. 67-73
DOI: 10.4236/ojcd.2013.32013    3,208 Downloads   5,792 Views   Citations
Author(s)    Leave a comment

ABSTRACT

This comparative study has been focused on the prevalence of MRSA types and their antibiotic resistance in two tertiary care hospitals of Nepal. During November 2007 to June 2009, clinical samples from patients with nosocomial infection from two Nepali hospitals, Kathmandu Based Hospital (KBH) and Lalitpur Based Hospital (LBH) were cultured and antibiotic susceptibility tests done following standard methodology in Microbiology laboratory, Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Occurrence of MRSA (52.9% of 304 Staphylococcus aureus isolates) in KBH and that of MSSA (62% of 100 S. aureus isolates) in LBH were significant. No association of age was observed with MRSA or MSSA. Among MSSA from both hospitals, the highest resistance was found against penicillin. KBH urinary isolates were resistant to norfloxacin (51.4%), while isolates from other sites were resistant to ciprofloxacin (30.6%), erythromycin (12%), gentamicin (10.3%). LBH isolates were resistant to co-trimoxazole (22.6%), erythromycin (17.2%), ciprofloxacin (13.8%), gentamicin (12.9%). Among MRSA, most of the isolates from both hospitals were resistant to a wide array of antibiotics. A majority of the MSSA and MRSA isolates were susceptible to rifampicin and chloramphenicol. Most of KBH MRSA were homogeneous MRSA, 80.5% (significant), of which, 99.2% were multiresistant oxacillin resistant S. aureus (MORSA). And among the heterogeneous MRSA isolates from KBH, 71% were MORSA. On the other hand, among LBH MRSA isolates, 52.6% were homogeneous MRSA, cent percent of which were MORSA while 47.4% were heterogeneous MRSA of which 44.5% were MORSA. Since almost all of the homogeneous MRSA and most of the heterogeneous MRSA from both hospitals were MORSA, there is a possibility that a hospital acquired S. aureus could be MORSA. Hence, every infected patient should be considered as a potential source of MORSA.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Shrestha, B. (2013) Comparative prevalence of MRSA in two Nepalese tertiary care hospitals. Open Journal of Clinical Diagnostics, 3, 67-73. doi: 10.4236/ojcd.2013.32013.

References

[1] Wenzel, R.P. (1994) Healthcare workers and the incidence of nosocomial infection: Can treatment of one influence the other? A brief review. Journal of Chemotherapy, 6, 33-37, 39-40.
[2] Simor, A., Ofner-Agostini, M. and Patin, S. (1997) The Canadian Nosocomial Infection Surveillance Program: Results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals. Canada Communicable Disease Report, 23, 41-45.
[3] Witte, W. (1999) Antibiotic resistance in gram positive bacteria: Epidemiological aspects. Journal of Antimicrobial Chemotherapy, 44, 1-9. doi:10.1093/jac/44.suppl_1.1
[4] Panlilio, A.L., Culver, D.H., Gaynes, R.P., Banerjee, S., Hendersen, T.S., Tolson, J.S. and Martone, W.J. (1992) Methicillin resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infection Control and Hospital Epidemiology, 13, 582-586. doi:10.1086/646432
[5] Bartlett, M., Mclntyre, L., Mosoley, R., O’Connor, j., Shaw, J. and Whitehead, C. (2002) Methicillin resistant Staphylococcus aureus rates increase 260% in hospitals participating in HIP’s international monitoring systems. Center for Disease Control and National Center for Infectious Diseases Focus, 9, 4.
[6] Kim, T., Oh, P.I. and Simor, A.E. (2001) The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infection Control and Hospital Epidemiology, 22, 99-104. doi:10.1086/501871
[7] Hartman, B.S. and Tomasz, A. (1984) A low affinity penicillin binding protein associated in beta lactam resistance in Staphylococcus aureus. Journal of Bacteriology, 158, 513-516.
[8] Katayama, Y., Ito, T. and Hiramatsu, K. (2001) Genetic organization of the chromosome region surrounding mecA Clinical Staphylococcal strains: Role of IS431-mediated mecI deletion in expression of resistance in mecA carrying low level methicillin resistance Staphylococcus haemolyticus. Antimicrobial Agents and Chemotherapy, 45, 1955-1963. doi:10.1128/AAC.45.7.1955-1963.2001
[9] Hurlimenn-Dalel, R.L., Ruffel, C., Kayser, F.H. and Berger-Bachi, B. (1992) Survey of methicillin resistance associated genes mecA, mecR1-mecI and femA-femB in clinical isolates of MRSA. Antimicrobial Agents and Chemotherapy, 36, 2617-2621. doi:10.1128/AAC.36.12.2617
[10] Ito, T., Max, X., Tekuchi, F., Okuma, K., Yuzawa, H. and Hiramatsu, K. (2004) Novel type V SCCmec driven by a novel cassette chromosome recombinaseccrC. Antimicrobial Agents and Chemotherapy, 48, 2637-2651. doi:10.1128/AAC.48.7.2637-2651.2004
[11] Centers for Disease Control and Prevention (2010) About antimicrobial resistance: A brief overview. www.cdc.gov/drugresistance/about.htm
[12] Chambers, H.F. (1988) Methicillin resistant staphylococci. Clinical Microbiology Reviews, 1, 173-186.
[13] Chambers, H.F. (1997) Methicillin resistance in staphylococci: Molecular and Biochemical basis and clinical implications. Clinical Microbiology Reviews, 10, 781- 791.
[14] Isenberg, H.D. (2004) Clinical microbiology procedure handbook Vol. 1, American Society for Microbiology. ASM Press, Washington DC.
[15] Clinical Laboratory Standards Institute (2007) Performance standard for antimicrobial susceptibility testing: Seventeenth informational supplement M100-S17, Vol. 27, No. 1. Clinical Laboratory Standards Institute, Wayne.
[16] Clinical Laboratory Standards Institute (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition. M7-A7, Vol. 27, No. 2. Clinical Laboratory Standard Institute, Wayne.
[17] Gosbell, I.B., Neville, S.A., Mercer, J.L., Fernandes, L.A. and Fernandes, C.J. (2001) Evaluation of the MRSA-screen test in detecting oxacillin resistance in community and hospital isolates of Staphylococcus aureus. Pathology, 33, 493-495. doi:10.1080/00313020120083214
[18] Boyce, J.M. (1989). Methicillin resistant Staphylococcus sureus detection, epidemiology and control measures. Infectious Disease Clinics of North America, 3, 901-913.
[19] Klevens, M.R., Morrison, M.A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L.H., Lynfield, R., Dumyati, G., Townes, J.M., Craig, A.S., Zell, E.R., Forsheim, G.E., McDougal, L.K., Carey, R.B. and Fridkin, S.K. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of American Medical Association, 298, 1763-1771. doi:10.1001/jama.298.15.1763
[20] Lepelletier, D., Ferreol, S. and Villers, D. (2004) Methicillin resistant Staphylococcus aureus nosocomial infection in ICU: Risk factors, morbidity and cost. PathologieBiologie, 52, 474-479. doi:10.1016/j.patbio.2004.06.002
[21] Huang, H., Flynn, M., King, J.H. and Monchaud, C. (2006) Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. Journal of Clinical Microbiology, 44, 2423-2427. doi:10.1128/JCM.00254-06
[22] Centers for Disease Control and Prevention (2005) Laboratory detection of: Oxacillin/methicillin-resistant Staphylococcus aureus. www.cdc.gov/mrsa/lab/lab-detection.html
[23] Kotilainen, P., Nikoskelainen, J. and Huovinen, P. (1990) Emergence of ciprofloxacin resistant coagulase negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. Journal of Infectious Diseases, 161, 41-44. doi:10.1093/infdis/161.1.41
[24] Shrestha, B., Pokhrel, B.M. and Mohapatra, T.M. (2009) Antibiotic susceptibility pattern of nosocomial isolates of Staphylococcus aureus in a tertiary care hospital, Nepal. Journal of Nepal Medical Association, 48, 234-238.
[25] Alestig, K. (2004) Tetracyclines and chloramphenicol. In: Cohen, J. and Powdwely, W.G., Eds., Infectious diseases, 2nd Edition, Harcourt Publishers Limited, Edinburgh, 1843-1847.
[26] Shrestha, B., Pokhrel, B.M. and Mohapatra, T.M. (2009) Phenotypic characterization of nosocomial isolates of Staphylococcus aureuswith reference to MRSA. Journal of Infection in Developing Countries, 3, 554-560. doi:10.3855/jidc.474
[27] Zinn, C.S., Westh, H., Rosdahl, V.T. and Sarisa Study Group (2004) An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microbial Drug Resistance, 10, 160-168. doi:10.1089/1076629041310055
[28] Haley, R.W., Hightower, A.W., Khabbaz, R.F., Thornsberry, C., Martone, W.J., Allen, J.R. and Hughes, J.M. (1982) The emergence of methicillin resistant Staphylococcus aureus in United States hospitals. Possible role of house staff-patient transfer circuit. Annals of Internal Medicine, 97, 297-308. doi:10.7326/0003-4819-97-3-297
[29] Vriens, M.R., Fluit, A.C., Troelstra, A. and Vander, W.C. (2002) Is methicillin resistant Staphylococcus aureus more contagious than methicillin susceptible S. aureus in a surgical intensive care unit? Infection Control and Hospitalepidemiology, 23, 491-494. doi:10.1086/502094
[30] Hsueh, P.R., Teng, L.J., Chen, W.H., Pan, H.J., Chen, M.L., Chang, S.C., Luh, K.T. and Lin, F.Y. (2004) Increasing prevalence of methicillin resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrobial Agents and Chemotherapy, 48, 1361-1364. doi:10.1128/AAC.48.4.1361-1364.2004
[31] Thompson, R.L., Cabezudo, I. and Wenzel, R.P. (1982) Epidemiology of nosocomial infections caused by methicillin resistant Staphylococcus aureus. Annals of Internal Medicine, 97, 309-317. doi:10.7326/0003-4819-97-3-309
[32] Udo, E.E, Panigrahi, D. and Jamsheer, A.E. (2008) Molecular typing of methicillin resistant Staphylococcus aureus isolated from Bahrain hospital. Medical Principles and Practice, 17, 308-314. doi:10.1159/000129611
[33] Cosgrove, S.E. (2006) The relationship between antimicrobial resistance and patient outcome: Mortality, length of hospital stay, and health care cost. Clinical Infectious Diseases, 42, S82-S89. doi:10.1086/499406
[34] Centers for Disease Control and Prevention (1992) Public health focus: Surveillance, prevention and control of nosocomial infections. Morbidity Mortality Weekly Report, 41, 783-787.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.